Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rohtesh Mehta

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Journal of Palliative Medicine|January 25, 2012
Insomnia: patient assessment #101Robert M Arnold, Michael Miller, Rohtesh Mehta
Therapeutic Advances in Hematology|January 11, 2018
New and emerging therapies for acute and chronic graft <i>versus</i> host diseaseLaQuisa Hill, Amin Alousi, Partow Kebriaei, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|August 24, 2012
CD123 immunohistochemical expression in acute myeloid leukemia is associated with underlying FLT3-ITD and NPM1 mutationsMarian Rollins-Raval, Raju Pillai, Katsuhiko Warita, et al.
Transplantation and Cellular Therapy|June 13, 2025
Seizure prophylaxis and its impact on busulfan pharmacokinetics and dosing in a novel timed sequential protocol: MD Anderson experienceJitesh D Kawedia, Victoria W Handy, Alan L Myers, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 12, 2018
Allotransplants for Patients 65 Years or Older with High-Risk Acute Myeloid LeukemiaLauren Veltri, Katayoun Rezvani, Betul Oran, et al.
Contemporary Clinical Trials|July 22, 2024
Study Protocol: Predicting the Quality of Response to Specific Treatments (PQRST) in Chronic Graft-versus-Host DiseaseBetty K Hamilton, Lynn Onstad, Paul A Carpenter, et al.
Haematologica|July 13, 2019
Mixed myeloid chimerism and relapse of myelofibrosis after allogeneic stem cell transplantationSamer A Srour, Amanda Olson, Stefan O Ciurea, et al.
Haematologica|July 24, 2025
Guadecitabine improved relapse-free survival in high-risk acute myeloid leukemia and myelodysplastic syndrome patients after transplant: phase II results from a single centerBetül Oran, Peter Thall, Amin Alousi, et al.
Transplantation and Cellular Therapy|April 1, 2024
Returning to Work Following Hematopoietic Cell Transplantation: The Survivor's PerspectiveRachel B Salit, Stephanie J Lee, Neel S Bhatt, et al.
Blood|December 12, 2019
Is there an optimal conditioning for older patients with AML receiving allogeneic hematopoietic cell transplantation?Stefan O Ciurea, Piyanuch Kongtim, Ankur Varma, et al.
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Journal of Palliative Medicine|January 25, 2012
Insomnia: patient assessment #101Robert M Arnold, Michael Miller, Rohtesh Mehta
Therapeutic Advances in Hematology|January 11, 2018
New and emerging therapies for acute and chronic graft <i>versus</i> host diseaseLaQuisa Hill, Amin Alousi, Partow Kebriaei, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|August 24, 2012
CD123 immunohistochemical expression in acute myeloid leukemia is associated with underlying FLT3-ITD and NPM1 mutationsMarian Rollins-Raval, Raju Pillai, Katsuhiko Warita, et al.
Transplantation and Cellular Therapy|June 13, 2025
Seizure prophylaxis and its impact on busulfan pharmacokinetics and dosing in a novel timed sequential protocol: MD Anderson experienceJitesh D Kawedia, Victoria W Handy, Alan L Myers, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 12, 2018
Allotransplants for Patients 65 Years or Older with High-Risk Acute Myeloid LeukemiaLauren Veltri, Katayoun Rezvani, Betul Oran, et al.
Contemporary Clinical Trials|July 22, 2024
Study Protocol: Predicting the Quality of Response to Specific Treatments (PQRST) in Chronic Graft-versus-Host DiseaseBetty K Hamilton, Lynn Onstad, Paul A Carpenter, et al.
Haematologica|July 13, 2019
Mixed myeloid chimerism and relapse of myelofibrosis after allogeneic stem cell transplantationSamer A Srour, Amanda Olson, Stefan O Ciurea, et al.
Haematologica|July 24, 2025
Guadecitabine improved relapse-free survival in high-risk acute myeloid leukemia and myelodysplastic syndrome patients after transplant: phase II results from a single centerBetül Oran, Peter Thall, Amin Alousi, et al.
Transplantation and Cellular Therapy|April 1, 2024
Returning to Work Following Hematopoietic Cell Transplantation: The Survivor's PerspectiveRachel B Salit, Stephanie J Lee, Neel S Bhatt, et al.
Blood|December 12, 2019
Is there an optimal conditioning for older patients with AML receiving allogeneic hematopoietic cell transplantation?Stefan O Ciurea, Piyanuch Kongtim, Ankur Varma, et al.
Pageof 5